Personalis, Inc. Noncash or Part Noncash Acquisition, Payables Assumed
Personalis, Inc. (PSNL) reported Noncash or Part Noncash Acquisition, Payables Assumed of $1.74 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1 · last filed 2026-08-04
- Personalis, Inc. noncash or part noncash acquisition, payables assumed for the quarter ending 2026-06-30 was -$1.30M, a 2598.08% decline year-over-year.
- Personalis, Inc. noncash or part noncash acquisition, payables assumed for the quarter ending 2026-03-31 was $3.04M, a 1065.90% increase year-over-year.
- Personalis, Inc. noncash or part noncash acquisition, payables assumed for the quarter ending 2025-12-31 was $24.00K.
- Personalis, Inc. noncash or part noncash acquisition, payables assumed for the quarter ending 2025-09-30 was $2.21M.
- Personalis, Inc. noncash or part noncash acquisition, payables assumed for fiscal 2025 was $2.55M, a 438.48% increase from fiscal 2024.
- Personalis, Inc. noncash or part noncash acquisition, payables assumed for fiscal 2024 was $473.00K, a 354.81% increase from fiscal 2023.
- Personalis, Inc. noncash or part noncash acquisition, payables assumed for fiscal 2023 was $104.00K, a 97.34% decline from fiscal 2022.
- Personalis, Inc. noncash or part noncash acquisition, payables assumed for fiscal 2022 was $3.92M, a 30.31% increase from fiscal 2021.
| Period end | Noncash or Part Noncash Acquisition, Payables Assumed 3 month | Noncash or Part Noncash Acquisition, Payables Assumed 6 month | Noncash or Part Noncash Acquisition, Payables Assumed 9 month | Noncash or Part Noncash Acquisition, Payables Assumed 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.74M 10-Q · filed 2026-08-04 | $1.77M derived: sum of 3 quarters · filed 2026-08-04 | $3.98M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $3.04M 10-Q · filed 2026-05-07 | $3.07M derived: sum of 2 quarters · filed 2026-05-07 | $5.28M derived: sum of 3 quarters · filed 2026-05-07 | $5.33M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.23M derived: sum of 2 quarters · filed 2026-02-26 | $2.29M derived: sum of 3 quarters · filed 2026-08-04 | $2.55M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.26M derived: sum of 2 quarters · filed 2026-08-04 | $2.52M 10-Q · filed 2025-11-04 | $1.99M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $313.00K 10-Q · filed 2026-08-04 | -$224.00K derived: sum of 3 quarters · filed 2026-08-04 | |
| 2025-03-31 | $261.00K 10-Q · filed 2026-05-07 | -$276.00K derived: sum of 2 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -$537.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $473.00K 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $1.01M 10-Q · filed 2025-11-04 | |||
| 2023-12-31 | $104.00K 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $3.92M 10-K · filed 2024-02-28 | |||
| 2021-12-31 | $3.01M 10-K · filed 2024-02-28 | |||
| 2020-12-31 | $282.00K 10-K · filed 2023-02-23 | |||
| 2019-12-31 | $41.00K 10-K · filed 2022-02-24 | |||
| 2018-12-31 | $323.00K 10-K · filed 2021-02-25 | |||
| 2017-12-31 | $521.00K 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |